Approach:

Reducing the likelihood is focused on:

Demonstrating in-space monitoring capabilities, outlining necessary training, developing medical system requirements, and providing examples of representative technology solutions (e.g. Autonomous Medical Officer Support software technology demonstration)

Incorporating renal stone computational models into trade space analysis tools for the purpose of developing integrated exploration medical system models

Considering of known or novel pharmaceutical countermeasures for inclusion in exploration candidate formulary (please refer to pharm risk for more information)

Reducing the consequence is focused on:

Defining conservative renal stone management capabilities, outlining necessary training, and incorporating capabilities into exploration medical system models

Completing the in-process “renal stone management technology development and clinical validation study”